Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Systemic corticosteroids for acute exacerbations
4 evidence topics · 4 sources
International guideline: short rescue course for acute exacerbations and against long-term use
“We recommend against the long‐term use of systemic glucocorticosteroids or depot preparations in CU.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We suggest considering a short course of rescue systemic glucocorticosteroids in patients with an acute exacerbation of CU.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For acute urticaria and acute exacerbations of CSU, a short course of oral corticosteroids, that is, treatment of a maximum of up to 10 days, may, however, be helpful to reduce disease duration/activity” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Nevertheless, well‐designed randomized clinical trials are lacking.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
International guideline: prednisone-equivalent dose, licensing, and use in children
“If systemic corticosteroids are used, doses between 20–50 mg/day of prednisone equivalent are needed (dose is appropriate for adults and not children).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Because such high doses will have side effects over the long term, we strongly recommend against the prolonged use of corticosteroids.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Depending on the country it must be noted that steroids are also not licensed for CU” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“a short course of corticosteroids as advised in the algorithm should be used only as a very restricted measure in children.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Corticosteroid use, adverse events, and health care resource use in a Novartis-funded US claims study
“This retrospective cohort study used data from the US HealthVerity claims database of adults with diagnosed CSU (January 2016–March 2023).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Of 200,298 patients, corticosteroids were the most prescribed treatment (78.3% all; 68.2% systemic) following CSU diagnosis, excluding over-the-counter medication and antihistamines.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The ten most common AEs occurring after systemic corticosteroid initiation (hypertension, lipid disorders, anxiety, obesity, fatigue, depression, diabetes, insomnia, cataracts, and gastritis) occurred in higher proportions of all corticosteroid user types versus non-users.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The proportion of patients experiencing AEs generally increased with longer duration of corticosteroid use.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“More frequent HCRU was generally observed after the first systemic corticosteroid prescription and with increasing duration of corticosteroid use.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This study and article publication, including the journal’s Rapid Service Fee, was funded by Novartis Pharmaceuticals Corporation” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Corticosteroids as the most prescribed treatment in a US claims cohort with diagnosed CSU
“Adults with a record of CSU diagnosis within the US HealthVerity claims database were eligible.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Corticosteroids were the most prescribed treatment during follow-up among the 166,195 patients prescribed at least 1 treatment (94.3%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote